Promoting Pediatric Drug Research and Labeling - Outcomes of Legislation

N Engl J Med. 2019 Aug 29;381(9):875-881. doi: 10.1056/NEJMhle1901265.

Authors

Florence T Bourgeois¹, Aaron S Kesselheim¹

Affiliation

¹ From the Pediatric Therapeutics and Regulatory Science Initiative and the Computational Health Informatics Program, Boston Children's Hospital, and the Department of Pediatrics, Harvard Medical School (F.T.B.), and the Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School (A.S.K.) - all in Boston.

PMID: 31461599
DOI: 10.1056/NEJMhle1901265

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Child
Clinical Trials as Topic / legislation & jurisprudence
Drug Development / legislation & jurisprudence*
Government Regulation*
Humans
United States
United States Food and Drug Administration / legislation & jurisprudence